Medtronic PLC Net Income
| MDT Stock | USD 99.49 1.39 1.38% |
As of the 15th of February 2026, Medtronic PLC secures the Risk Adjusted Performance of 0.085, mean deviation of 0.9073, and Downside Deviation of 0.9055. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medtronic PLC, as well as the relationship between them.
Medtronic PLC Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 4.3185 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 5.4 B | 5.7 B | |
| Net Income Applicable To Common Shares | 5.4 B | 3.3 B | |
| Net Income From Continuing Ops | 5.4 B | 4.3 B | |
| Net Income Per Share | 3.26 | 3.43 | |
| Net Income Per E B T | 0.75 | 0.59 |
Medtronic | Net Income | Build AI portfolio with Medtronic Stock |
The evolution of Net Income for Medtronic PLC provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medtronic PLC compares to historical norms and industry peers.
Latest Medtronic PLC's Net Income Growth Pattern
Below is the plot of the Net Income of Medtronic PLC over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Medtronic PLC financial statement analysis. It represents the amount of money remaining after all of Medtronic PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Medtronic PLC's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medtronic PLC's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 4.69 B | 10 Years Trend |
|
Net Income |
| Timeline |
Medtronic Net Income Regression Statistics
| Arithmetic Mean | 3,805,827,353 | |
| Geometric Mean | 3,069,142,806 | |
| Coefficient Of Variation | 33.74 | |
| Mean Deviation | 882,220,415 | |
| Median | 3,676,000,000 | |
| Standard Deviation | 1,283,977,299 | |
| Sample Variance | 1648597.7T | |
| Range | 5.6B | |
| R-Value | 0.74 | |
| Mean Square Error | 796775.9T | |
| R-Squared | 0.55 | |
| Significance | 0.0007 | |
| Slope | 188,036,324 | |
| Total Sum of Squares | 26377563.3T |
Medtronic Net Income History
Other Fundumenentals of Medtronic PLC
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Medtronic PLC Net Income component correlations
Medtronic Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Medtronic PLC is extremely important. It helps to project a fair market value of Medtronic Stock properly, considering its historical fundamentals such as Net Income. Since Medtronic PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medtronic PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medtronic PLC's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Medtronic introduce new products? Factors like these will boost the valuation of Medtronic PLC. Expected growth trajectory for Medtronic significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.081 | Dividend Share 2.82 | Earnings Share 3.69 | Revenue Per Share | Quarterly Revenue Growth 0.066 |
Understanding Medtronic PLC requires distinguishing between market price and book value, where the latter reflects Medtronic's accounting equity. The concept of intrinsic value - what Medtronic PLC's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Medtronic PLC's price substantially above or below its fundamental value.
Understanding that Medtronic PLC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medtronic PLC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medtronic PLC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Medtronic PLC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medtronic PLC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medtronic PLC.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Medtronic PLC on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Medtronic PLC or generate 0.0% return on investment in Medtronic PLC over 90 days. Medtronic PLC is related to or competes with Stryker, HCA Holdings, Boston Scientific, McKesson, Vertex Pharmaceuticals, Sanofi ADR, and Edwards Lifesciences. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinic... More
Medtronic PLC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medtronic PLC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medtronic PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.9055 | |||
| Information Ratio | 0.0452 | |||
| Maximum Drawdown | 6.95 | |||
| Value At Risk | (1.38) | |||
| Potential Upside | 2.41 |
Medtronic PLC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medtronic PLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medtronic PLC's standard deviation. In reality, there are many statistical measures that can use Medtronic PLC historical prices to predict the future Medtronic PLC's volatility.| Risk Adjusted Performance | 0.085 | |||
| Jensen Alpha | 0.1071 | |||
| Total Risk Alpha | 0.0234 | |||
| Sortino Ratio | 0.0627 | |||
| Treynor Ratio | 0.7324 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medtronic PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medtronic PLC February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.085 | |||
| Market Risk Adjusted Performance | 0.7424 | |||
| Mean Deviation | 0.9073 | |||
| Semi Deviation | 0.7669 | |||
| Downside Deviation | 0.9055 | |||
| Coefficient Of Variation | 991.12 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.58 | |||
| Information Ratio | 0.0452 | |||
| Jensen Alpha | 0.1071 | |||
| Total Risk Alpha | 0.0234 | |||
| Sortino Ratio | 0.0627 | |||
| Treynor Ratio | 0.7324 | |||
| Maximum Drawdown | 6.95 | |||
| Value At Risk | (1.38) | |||
| Potential Upside | 2.41 | |||
| Downside Variance | 0.8199 | |||
| Semi Variance | 0.5882 | |||
| Expected Short fall | (1.15) | |||
| Skewness | 1.12 | |||
| Kurtosis | 1.97 |
Medtronic PLC Backtested Returns
Currently, Medtronic PLC is very steady. Medtronic PLC has Sharpe Ratio of 0.0582, which conveys that the firm had a 0.0582 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Medtronic PLC, which you can use to evaluate the volatility of the firm. Please verify Medtronic PLC's Mean Deviation of 0.9073, downside deviation of 0.9055, and Risk Adjusted Performance of 0.085 to check out if the risk estimate we provide is consistent with the expected return of 0.0722%. Medtronic PLC has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.16, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medtronic PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medtronic PLC is expected to be smaller as well. Medtronic PLC right now secures a risk of 1.24%. Please verify Medtronic PLC value at risk, and the relationship between the jensen alpha and skewness , to decide if Medtronic PLC will be following its current price movements.
Auto-correlation | -0.54 |
Good reverse predictability
Medtronic PLC has good reverse predictability. Overlapping area represents the amount of predictability between Medtronic PLC time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medtronic PLC price movement. The serial correlation of -0.54 indicates that about 54.0% of current Medtronic PLC price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.54 | |
| Spearman Rank Test | -0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 4.09 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Medtronic Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Medtronic PLC reported net income of 4.69 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is significantly lower than that of the firm.
Medtronic Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic PLC's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic PLC could also be used in its relative valuation, which is a method of valuing Medtronic PLC by comparing valuation metrics of similar companies.Medtronic PLC is currently under evaluation in net income category among its peers.
Medtronic PLC ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.Environmental | Governance | Social |
Medtronic PLC Institutional Holders
Institutional Holdings refers to the ownership stake in Medtronic PLC that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Medtronic PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medtronic PLC's value.| Shares | Amvescap Plc. | 2025-06-30 | 17.6 M | Goldman Sachs Group Inc | 2025-06-30 | 17.6 M | Norges Bank | 2025-06-30 | 16.4 M | Ameriprise Financial Inc | 2025-06-30 | 14.6 M | Northern Trust Corp | 2025-06-30 | 12.2 M | Franklin Resources Inc | 2025-06-30 | 11.8 M | Royal Bank Of Canada | 2025-06-30 | 11.1 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 10.3 M | Citadel Advisors Llc | 2025-06-30 | 9.8 M | Vanguard Group Inc | 2025-06-30 | 126.9 M | Blackrock Inc | 2025-06-30 | 122.4 M |
Medtronic Fundamentals
| Return On Equity | 0.0982 | ||||
| Return On Asset | 0.0469 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 150.1 B | ||||
| Shares Outstanding | 1.28 B | ||||
| Shares Owned By Insiders | 0.29 % | ||||
| Shares Owned By Institutions | 88.30 % | ||||
| Number Of Shares Shorted | 19.72 M | ||||
| Price To Earning | 20.44 X | ||||
| Price To Book | 2.66 X | ||||
| Price To Sales | 3.67 X | ||||
| Revenue | 33.54 B | ||||
| Gross Profit | 22.79 B | ||||
| EBITDA | 9.22 B | ||||
| Net Income | 4.69 B | ||||
| Cash And Equivalents | 2.22 B | ||||
| Cash Per Share | 8.59 X | ||||
| Total Debt | 28.52 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 37.95 X | ||||
| Cash Flow From Operations | 7.04 B | ||||
| Short Ratio | 2.60 X | ||||
| Earnings Per Share | 3.69 X | ||||
| Price To Earnings To Growth | 3.56 X | ||||
| Target Price | 112.0 | ||||
| Number Of Employees | 95 K | ||||
| Beta | 0.72 | ||||
| Market Capitalization | 127.61 B | ||||
| Total Asset | 91.68 B | ||||
| Retained Earnings | 31.48 B | ||||
| Working Capital | 10.94 B | ||||
| Current Asset | 23.6 B | ||||
| Current Liabilities | 7.17 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 2.18 % | ||||
| Net Asset | 91.68 B | ||||
| Last Dividend Paid | 2.82 |
About Medtronic PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.